Royce & Associates »

Travere Therapeutics shares owned by Royce & Associates

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Royce & Associates from 13F filings

Historical chart of Royce & Associates investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Royce & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $374k 42k 8.99
2023-09-30 $164k 18k 8.94